Most providers recommend beginning at 0.25mg per week for the first 4 weeks to allow the body to adjust to the medication
Ozempic Use Linked to Adverse Gastrointestinal Events Study Highlight: Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss In October 2023, researchers at the University of British Columbia published findings in the Journal of the American Medical Association (JAMA), which found an increased risk of adverse gastrointestinal events associated with GLP-1 receptor agonists used for weight loss
These labs typically include an obesity lab panel, which measures CBC (blood count), CMP (metabolic function), lipids (cholesterol levels), A1C (diabetes), TSH (thyroid function), and insulin
Duan L, Zhang Y, Yang Y, Su S, Zhou L, Lo P-C, Cai J, Qiao Y et al (2021) Baicalin inhibits ferroptosis in intracerebral hemorrhage